Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression
Anna Pegoraro, Elisa Orioli, Elena De Marchi, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

P2X7 receptor and the NLRP3 inflammasome: Partners in crime
Pablo Pelegrı́n
Biochemical Pharmacology (2020) Vol. 187, pp. 114385-114385
Closed Access | Times Cited: 148
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells
Anna Pegoraro, Elena De Marchi, Manuela Ferracin, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 12
Open Access | Times Cited: 54
P2X7 Variants in Oncogenesis
Anna Pegoraro, Elena De Marchi, Elena Adinolfi
Cells (2021) Vol. 10, Iss. 1, pp. 189-189
Open Access | Times Cited: 51
Structural basis for the functional properties of the P2X7 receptor for extracellular ATP
Lin‐Hua Jiang, Emily A. Caseley, Steve P. Muench, et al.
Purinergic Signalling (2021) Vol. 17, Iss. 3, pp. 331-344
Open Access | Times Cited: 46
Role of ATP in Extracellular Vesicle Biogenesis and Dynamics
Marta Lombardi, Martina Gabrielli, Elena Adinolfi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 41
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
Michele Zanoni, Alba Clara Sarti, Alice Zamagni, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Purinergic signaling: Diverse effects and therapeutic potential in cancer
Jasmeet Kaur, Sanchit Dora
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
Extracellular ATP Mediates Cancer Cell Migration and Invasion Through Increased Expression of Cyclooxygenase 2
Shilpa Sharma, Harshit Kalra, Ravi Shankar Akundi
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 35
The P2X7 receptor as a new pharmacological target for retinal diseases
Chiara Bianca Maria Platania, Filippo Drago, Claudio Bucolo
Biochemical Pharmacology (2022) Vol. 198, pp. 114942-114942
Closed Access | Times Cited: 23
Purine and purinergic receptors in health and disease
Yanling Ai, Hengyi Wang, Lu Liu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 15
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
Séréna Janho dit Hreich, Paul Hofman, Valérie Vouret‐Craviari
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9235-9235
Open Access | Times Cited: 14
P2X7 receptor: a critical regulator and potential target for breast cancer
Xiaodi Zhu, Qianqian Li, Wei Song, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 3, pp. 349-358
Closed Access | Times Cited: 32
P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
Vanessa Fernandes Arnaud-Sampaio, Carolina Adriane Bento, Talita Glaser, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
P2X7 Receptor in Dendritic Cells and Macrophages: Implications in Antigen Presentation and T Lymphocyte Activation
Claudio Acuña‐Castillo, Alejandro Escobar, Moira García-Gómez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2495-2495
Open Access | Times Cited: 4
Unraveling the role of the P2X7 receptor in cancer radioresistance: Molecular insights and therapeutic implications
Seyedeh Nasibeh Mousavikia, Maryam Moghaddam Matin, Mohammad Taghi Bahreyni Tossi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025) Vol. 1872, Iss. 3, pp. 119910-119910
Closed Access
Effects of nanoflubendazole and purinergic signaling modulation in overcoming neuroblastoma chemoresistance
Renata Siqueira de Mello, Carolina Adriane Bento, Rafael de Oliveira Faria, et al.
Purinergic Signalling (2025)
Closed Access
P2X receptors in cancer growth and progression
Francesco Di Virgilio, Valentina Vultaggio-Poma, Alba Clara Sarti
Biochemical Pharmacology (2020) Vol. 187, pp. 114350-114350
Closed Access | Times Cited: 32
Animal Models for the Investigation of P2X7 Receptors
Ronald Sluyter, Sahil Adriouch, Stephen J. Fuller, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8225-8225
Open Access | Times Cited: 10
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice
Peter Cuthbertson, Amy Button, Chloe Sligar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1775-1775
Open Access | Times Cited: 3
The P2X7 Receptor: A Promising Pharmacological Target in Diabetic Retinopathy
Matteo Tassetto, Anna Scialdone, Anna Solini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7110-7110
Open Access | Times Cited: 22
Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor
Izadora L. A. Rabelo, Vanessa Fernandes Arnaud-Sampaio, Elena Adinolfi, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1782-1782
Open Access | Times Cited: 22
The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
Luke Tattersall, Karan M. Shah, Darren Lath, et al.
Journal of bone oncology (2021) Vol. 31, pp. 100398-100398
Open Access | Times Cited: 21
Alternatively Spliced Isoforms of the P2X7 Receptor: Structure, Function and Disease Associations
Sophie K. F. De Salis, Lanxin Li, Zheng Chen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8174-8174
Open Access | Times Cited: 16
Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance
Hamid Aria, Marzieh Rezaei, Shima Nazem, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Emerging roles of purinergic signaling in anti-cancer therapy resistance
Michele Zanoni, Anna Pegoraro, Elena Adinolfi, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top